Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

n. It is designed to instruct the patient’s immune system to produce an antibody response against angiotensin II. Angiotensin II is a small peptide in the body and part of the so-called renin-angiotensin system (RAS), an important regulator of blood pressure. Angiotensin II causes blood vessels to narrow,
resulting in increased blood pressure. In a phase IIa clinical trial, vaccination with CYT006-AngQb has been shown to reduce blood pressure by induction of antibodies that bind angiotensin II. Thereby, binding of angiotensin II to its receptors and subsequent narrowing of blood vessels should be decreased. The RAS has already been successfully targeted by three major classes of antihypertensive drugs on the market: inhibitors of the angiotensin-converting-enzyme (ACE), antagonists of the angiotensin II type I receptor (ARBs) and renin inhibitors. Like other antihypertensive drugs these also come with the need for daily dosing and fail to provide a solution for improving patient compliance. Treatment with CYT006-AngQb should allow for convenient dosing schedules and smooth control of blood pressure due to a sustained antibody response induced by vaccination.



About Cytos Biotechnology AG
Cytos Biotechnology AG is a public Swiss biotechnology company that specializes in the discovery, development and commercialization of a new class of biopharmaceutical products – the ImmunodrugsTM. ImmunodrugsTM are intended for use in the treatment and prevention of common chronic diseases, which afflict millions of people worldwide. ImmunodrugsTM are designed to instruct the patient’s immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. Taking advantage of the high flexibility of its ImmunodrugTM platform, Cytos Biotechnology has built a pipeline of different ImmunodrugTM candidates in various disease areas, of which 6 are currently in clinical development. The Imm
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:8/1/2014)... SAN DIEGO, Aug. 1, 2014 Arena ... provided a corporate update and reported financial results ... "We have continued to see ... including a 43% quarter-over-quarter increase in estimated total ... the 10,000 mark," said Jack Lief, Arena,s President ...
(Date:8/1/2014)... , Aug. 1, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds ... Potassium Nitrate Industry" and "2014 Deep Research Report ... reports to its research database. ... 2014 Deep Research Report on Global and China ... research report on China ...
(Date:7/31/2014)... Indien, August 1, 2014 ... Inc. gaben heute bekannt, vor kurzem für ... zur Schmerzbehandlung nach chirurgischen Eingriffen eine kommerzielle ... der Europäischen Union und weiterer europäischer Länder ... und mit Ropivacain gefüllte OneDose ReadyfusOR später ...
Breaking Medicine Technology:Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 2Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 3Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 4Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 5Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 2Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 3
... WORTH, Texas, Aug. 24, 2011 The UNT System Board ... authorized in the 82nd Texas legislative session. As part of ... and UNT Dallas, the College of Pharmacy students will earn ... graduate portion of their classes on the UNT Health Science ...
... Technologies, Inc. ( www.heartsine.com ), a world leader in ... the samaritan ® PAD 300P Public Access ... a school serving children and young people with intellectual ... (AED) is now available for Camphill staff enabling ...
Cached Medicine Technology:UNT Regents Approve New College of Pharmacy 2HeartSine® Technologies Donates Lifesaving AED to Camphill Special School 2
(Date:8/1/2014)... Blindness is a reversible ailment these ... of today, despite well-meaning efforts, still have a long way ... for reversing blindness that does not involve any kind of ... alternative medicine takes the “slack” from the mainstream by providing ... harmful surgeries. , Alternative health specialist Kevin Richardson actually ...
(Date:8/1/2014)... Cypress, CA (PRWEB) August 01, 2014 ... to advancing gynecologic endoscopic surgery, is pleased to ... societies, in the United States and Europe, which ... make available to surgeons an endoscopic dry lab ... proficiency of their endoscopic surgery skills. , Endoscopy ...
(Date:8/1/2014)... August 01, 2014 Surftech athletes Jack ... Oahu paddleboard World Championships this past weekend in Hawaii ... 3rd place finisher Zeb Walsh were all on stock ... of the race and athletes this year were treated ... making the course extremely challenging as well as very ...
(Date:8/1/2014)... iFitDress.com, a professional company of women’s dresses ... 2014 silver bridesmaid dresses recently. All of ... latest fashion trends. What’s more, they are now offered ... , iFitDress.com is one of the leading suppliers ... silver bridesmaid gowns, but also many other kinds of ...
(Date:7/31/2014)... Women over the age of 65 face numerous ... greater struggles against poverty and higher rates of asthma ... August issue of Annals of Allergy, Asthma and ... of Allergy, Asthma and Immunology (ACAAI), outlines the challenges ... practical solutions to improve their care. , ...
Breaking Medicine News(10 mins):Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2Health News:AAGL Announces It Has Joined With Other Medical Societies to Encourage Hospitals Teaching Endoscopic Surgery to Establish Simulator Labs for Training 2Health News:Surftech Bark Commander Sweeps Molokai2Oahu Stock Paddleboard Division 2Health News:iFitDress.com: Beautiful Silver Bridesmaid Dresses at Promotional Prices 2Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3
... Coalition of patients, practitioners and employers urges ... deployment of interoperable health,information technology, WASHINGTON, ... co-chaired by former Senator John Breaux and ... Eshoo,and Mike Rogers for introducing legislation that ...
... The Pennsylvania,Department of Health today is emphasizing ... for consumers not to eat Banquet brand and,store ... possible,Salmonella contamination., "Federal officials have already shared ... ensure Pennsylvanians are taking the,appropriate measures to protect ...
... Guttmacher,Institute,s latest report on world abortion rates is ... W. Mosher. The,study, just released today, argues that ... developing countries., Accurate numbers are impossible to ... illegal. Says Mosher: "Neither,Guttmacher nor anyone else knows ...
... have discovered a key protein that controls how stem ... move limbs, or smooth muscle cells that support blood ... Proceedings of the National Academy of Sciences (PNAS). ... of muscle types in the human fetus, but also ...
... Ohio, Oct. 10 PartsSource, the nation,s leading,supplier ... &,CEO, A. Ray Dalton has been selected as ... Business" award. This honor is given to,executives who ... new,businesses throughout their professional career. "I am ...
... ... geographically, WILMINGTON, N.C., Oct. 10 ... as senior vice,president of clinical operations for North America and Simon ... Colvin joins PPD from Eli Lilly and Company where he most ...
Cached Medicine News:Health News:Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation 2Health News:Salmonella Outbreak Traced to Banquet and Store Brand Frozen Pot Pies 2Health News:PRI Criticizes Guttmacher Report 2Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 2Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 3Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 4Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 5Health News:PPD Names VPs for North America and Asia 2Health News:PPD Names VPs for North America and Asia 3
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults....
... A & B Test simplifies rapid ... on the market just got easier ... and influenza B using one simple ... can focus on the results and ...
... Combo with Reference Line Test ... human chorionic gonadotropin (hCG) in ... test kit is used to ... is intended for professional and ...
... Experience the finest surgical-quality loupes ... set the standard for innovative optical ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. Make ...
Medicine Products: